​

Rockwell Medical (RMTI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RMTI Stock Forecast

Rockwell Medical (RMTI) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 261.45% increase from the last price of $0.83.

High: $3 Avg: $3 Low: $3 Last Closed Price: $0.83

RMTI Stock Rating

Rockwell Medical stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (62.50%), 2 Hold (12.50%), 4 Sell (25.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 4 2 10 Strong Sell Sell Hold Buy Strong Buy

RMTI Price Target Upside V Benchmarks

TypeNameUpside
StockRockwell Medical261.45%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks22.81%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.83$0.83$0.83
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 2611---2
Apr, 2611---2
Mar, 2611---2
Feb, 2611---2
Jan, 2611---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 24, 2025Raghuram SelvarajuH.C. Wainwright$3.00$1.26138.10%261.45%
Sep 04, 2024Raghuram SelvarajuH.C. Wainwright$9.00$3.19182.13%984.34%
Jul 17, 2023Raghuram SelvarajuH.C. Wainwright$11.00$4.19162.53%1225.30%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 24, 2025H.C. WainwrightBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold
Jul 17, 2023H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.83$-1.89$-0.36$-0.03$-0.15---
Avg Forecast$-3.74$-2.12$-0.40$0.01$-0.09$-0.07$-0.03$0.06
High Forecast$-3.70$-2.06$-0.39$0.01$-0.09$-0.07$-0.03$0.06
Low Forecast$-3.78$-2.18$-0.41$0.01$-0.09$-0.07$-0.03$0.06
Surprise %2.41%-10.85%-10.00%-400.00%66.67%---

Revenue Forecast

$0 $14B $28B $42B $56B $70B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$61.93M$72.81M$83.61M$101.49M$69.26B---
Avg Forecast$64.25M$69.80M$84.15M$100.32M$77.13M$76.83M$69.40M$74.90M
High Forecast$64.72M$71.21M$86.34M$102.93M$79.13M$78.83M$71.20M$76.85M
Low Forecast$63.78M$68.39M$81.97M$97.71M$75.12M$74.83M$67.60M$72.95M
Surprise %-3.61%4.31%-0.64%1.17%89698.12%---

Net Income Forecast

$-6B $-4B $-3B $-2B $-700M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-32.67M$-18.68M$-8.44M$-480.00K$-5.31B---
Avg Forecast$-87.23M$-62.32M$-8.59M$233.23K$-2.10M$-1.63M$-699.69K$1.40M
High Forecast$-86.40M$-49.86M$-6.87M$241.11K$-2.03M$-1.58M$-676.04K$1.45M
Low Forecast$-88.06M$-74.79M$-10.31M$225.35K$-2.17M$-1.69M$-723.33K$1.35M
Surprise %-62.54%-70.03%-1.75%-305.81%253060.76%---

RMTI Forecast FAQ

Is Rockwell Medical stock a buy?

Rockwell Medical stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that Rockwell Medical is a favorable investment for most analysts.

What is Rockwell Medical's price target?

Rockwell Medical's price target, set by 16 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 261.45% change from the previous closing price of $0.83.

How does Rockwell Medical stock forecast compare to its benchmarks?

Rockwell Medical's stock forecast shows a 261.45% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (22.81%).

What is the breakdown of analyst ratings for Rockwell Medical over the past three months?

  • May 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Rockwell Medical’s EPS forecast?

Rockwell Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.07, marking a -53.33% decrease from the reported $-0.15 in 2025. Estimates for the following years are $-0.03 in 2027, and $0.06 in 2028.

What is Rockwell Medical’s revenue forecast?

Rockwell Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $76.83M, reflecting a -99.89% decrease from the reported $69.26B in 2025. The forecast for 2027 is $69.4M, and $74.9M for 2028.

What is Rockwell Medical’s net income forecast?

Rockwell Medical's net income forecast for the fiscal year ending in December 2026 stands at $-1.633M, representing a -99.97% decrease from the reported $-5.314B in 2025. Projections indicate $-700K in 2027, and $1.4M in 2028.